# PROTOX THERAPEUTICS INC: Form D filings

PROTOX THERAPEUTICS INC, a biotechnology company in Vancouver, British Columbia, Canada, filed 2 Form D notices with the SEC in 2010. The latest, on October 12, 2010, reports an offering of $59.4 million with nothing sold yet to 2 investors.

Find out what PROTOX THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PROTOX%20THERAPEUTICS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PROTOX%20THERAPEUTICS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fprotox-therapeutics-inc-1384825)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PROTOX%20THERAPEUTICS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PROTOX%20THERAPEUTICS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fprotox-therapeutics-inc-1384825)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 885 West Georgia Street - Suite 1210, Box 1014 HSBC Building, Vancouver, British Columbia, Canada, V6C 3
- Phone: (604) 608-4211
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: British Columbia, Canada
- Revenue range: No Revenues
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1384825

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 12, 2010 | New notice | $59,431,399 | $0 | $59,431,399 | 2 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1384825/000114036110040678/0001140361-10-040678-index.htm) |
| Apr 15, 2010 | New notice | $404,352 | $226,398 | $177,954 | 3 | Mar 16, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1384825/000114036110016600/0001140361-10-016600-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Frank Holler | Director |  |
| Jack Geltosky | Director |  |
| Alexander Giaquinto | Director |  |
| Tom D'Orazio | Executive Officer |  |
| Nina Merchant | Executive Officer |  |
| Fahar Merchant | Executive Officer, Director |  |
| Jim Heppell | Director |  |
| John Parkinson | Executive Officer |  |
| Avtar Dhillon | Director |  |
| James Miller | Director |  |

[Every Form D from the week of Oct 11, 2010](https://specstream.ai/data/form-d/week/2010-10-11) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what PROTOX THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).